A Significant Growth Driver for the Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Is the Expansion Of Telehealth Services Driving The Market Growth Due To Increasing Remote Patient Care Needs
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In 2026 And What Value Is Projected For 2030?
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market has experienced significant expansion in recent years. Its valuation is set to climb from $1.69 billion in 2025 to $2.05 billion in 2026, reflecting a compound annual growth rate (CAGR) of 21.6%. The historical growth of this market can be attributed to several factors, including the increasing use of intravenous therapies in clinical care, a rising incidence of infusion-related complications, the expansion of hospital patient monitoring systems, the growing adoption of smart infusion devices, and an increased emphasis on medication safety protocols.
The market for artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring is projected to experience substantial expansion in the coming years. This sector is anticipated to reach a valuation of $4.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 21.3%. Several factors are driving this projected growth, including the rising implementation of AI-enabled infusion monitoring systems, an increasing need for IV therapy solutions delivered at home, the broadening scope of predictive patient safety analytics, the expanding integration of networked infusion devices, and a heightened focus on remote clinical oversight. Key developments expected during this forecast period involve a greater uptake of real-time IV flow analytics, increased application of AI for detecting infusion errors, deeper incorporation of intelligent infusion sensors, wider availability of remote IV therapy management, and a stronger emphasis on ensuring patient safety and regulatory adherence.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28921&type=smp
What Key Drivers Are Influencing The Growth Of The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
The growing adoption of telehealth services is anticipated to fuel the expansion of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market. These services involve delivering healthcare remotely through digital communication tools, encompassing virtual consultations, patient monitoring, and treatment. Its prevalence has increased, spurred by shifts in regulations and reimbursement frameworks established during the COVID-19 pandemic, which improved the accessibility and economic feasibility of virtual healthcare for both medical professionals and patients. The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring solution complements telehealth by allowing continuous, off-site tracking of patients’ IV treatments, proactively identifying issues, offering practical data to clinicians, and connecting smoothly with virtual care systems. This ensures prompt medical responses, enhances patient well-being, and optimizes the handling of care in home and outpatient environments. For instance, an April 2023 report from FAIR Health Inc., a US-based non-profit organization, indicated that national telehealth utilization in 2023 grew by 7.3%, moving from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the increasing adoption of telehealth services is a key factor propelling the expansion of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market.
What Are The Key Segments Of The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
The artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, Other Applications
4) By End-User: Healthcare Providers, Patients
Subsegments:
1) By Hardware: Patient Monitoring Devices, Sensors And Infusion Pumps, Communication Devices, Data Storage Systems
2) By Software: Predictive Analytics Software, Clinical Decision Support Software, Remote Monitoring Software, Data Management Software
3) By Services: Implementation And Integration Services, Maintenance And Support Services, Training And Education Services, Remote Monitoring Services
Who Are The Leading Companies Operating In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
Major companies operating in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.
Read the full artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market report here:
Which Region Is Expected To Register The Fastest Growth In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market?
North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-enhanced remote patient intravenous (iv) monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28921&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market 2026, By The Business Research Company
Ai In Medical Devices Global Market Report
https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report
Artificial Intelligence Or Machine Learning Ai Or Ml Medical Device Global Market Report
Artificial Intelligence In Healthcare Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
